acquired
Stage
About
Spark Therapeutics is a biotechnology company that develops and commercializes adeno-associated virus (AAV)-based gene therapies for inherited genetic diseases, including Luxturna for inherited retinal dystrophy.
Explore Spark Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.